CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis

International Journal of Biochemistry and Cell Biology

Volumn 69, Issue , 2015, Pages 1-10

  Koszałka, Patrycja ^a   Gołuńska, Monika ^a   Stanisławowski, Marcin ^a   Urban, Aleksandra ^a   Stasiłojć, Grzegorz ^a   Majewski, Marceli ^a   Wierzbicki, Piotr ^a   Składanowski, Andrzej C ^a   Bigda, Jacek ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

B16F10 melanoma; Ecto 5 nucleotidase; Metastasis; Tumor macrophage infiltration; Tumor neovascularization and angiogenesis

Indexed keywords

5' NUCLEOTIDASE; ALPHA,BETA METHYLENEADENOSINE DIPHOSPHATE; ANGIOGENIC FACTOR; ANTIBODY; CD105 ANTIBODY; ENDOGLIN; FIBROBLAST GROWTH FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; OXYGEN; PROTEIN BAD; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VEGFR2 ANTIBODY;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; B16F10 CELL LINE; BLOOD VESSEL; CAPILLARY DENSITY; CARCINOGENESIS; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; ENDOTHELIUM CELL; GENE SILENCING; HYPOXIA; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MELANOMA B16; MELANOMA CELL LINE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAINING; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM; WILD TYPE; ANIMAL; C57BL MOUSE; CANCER TRANSPLANTATION; CELL ADHESION; EXPERIMENTAL MELANOMA; GENETICS; KNOCKOUT MOUSE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; SECONDARY; SKIN TUMOR; TUMOR CELL LINE; TUMOR VOLUME; VASCULARIZATION;

5'-NUCLEOTIDASE; ANIMALS; CELL ADHESION; CELL LINE, TUMOR; MACROPHAGES; MALE; MELANOMA, EXPERIMENTAL; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; SKIN NEOPLASMS; TUMOR BURDEN;

EID: 84944319979     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2015.10.003     Document Type: Article

References (51)

1. P. Agostinho, P. Caseiro, A.C. Rego, E.P. Duarte, R.A. Cunha, and C.R. Oliveira Adenosine modulation of d-(3H)aspartate release in cultured retina cells exposed to oxidative stress Neurochem. Int. 36 2000 255 265
2. L. Airas, J. Niemela, and S. Jalkanen CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism J. Immunol. 165 2000 5411 5417
3. B. Allard, M. Turcotte, and J. Stagg CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth J. Biomed. Biotechnol. 2012 2012 1 8
4. B. Allard, M. Turcotte, K. Spring, S. Pommey, I. Royal, and J. Stagg Anti-CD73 therapy impairs tumor angiogenesis Int. J. Cancer 134 2014 1466 1473
5. J.A. Auchampach Adenosine receptors angiogenesis Circ. Res. 101 2007 1075 1077
6. M.P. Barr, D.J. Bouchier-Hayes, and J.J. Harmey Vascular endothelial growth factor is an autocrine survival factor for breast tumour cells under hypoxia Int. J. Oncol. 32 2008 41 48
7. P.A. Beavis, J. Stagg, P.K. Darcy, and M.J. Smyth CD73: a potent suppressor of antitumor immune responses Trends Immunol. 33 2012 231 237
8. P.A. Beavis, U. Divisekera, C. Paget, M.T. Chow, L.B. John, C. Devaud, K. Dwyer, J. Stagg, M.J. Smyth, and P.K. Darcy Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors Proc. Natl. Acad. Sci. U.S.A. 110 2013 14711 14716
9. L.S. Bergamin, E. Braganhol, F. Figueiró, E.A. Casali, R.F. Zanin, J. Sévigny, and A.M. Battastini Involvement of purinergic system in the release of cytokines by macrophages exposed to glioma-conditioned medium J. Cell. Biochem. 116 2015 721 729
10. R.D. Bonfil, A. Vinyals, O.D. Bustuoabad, A. Llorens, F.J. Benavides, M. Gonzalez-Garrigues, and A. Fabra Stimulation of angiogenesis as an explanation of Matrigel-enhanced tumorigenicity Int. J. Cancer 58 1994 233 239
11. Y.C. Böring, U. Flögel, C. Jacoby, M. Heil, W. Schaper, and J. Schrader Lack of ecto-5′-nucleotidase (CD73) promotes arteriogenesis Cardiovasc. Res. 97 2013 88 96
12. S. Burghoff, X. Gong, C. Viethen, C. Jacoby, U. Flögel, S. Bongardt, A. Schorr, A. Hippe, B. Homey, and J. Schrader Growth and metastasis of B16-F10 melanoma cells is not critically dependent on host CD73 expression in mice BMC Cancer 14 2014 898
13. B. Chen, M.S. Longtine, Y. Sadovsky, and D.M. Nelson Hypoxia downregulates p53 but induces apoptosis and enhances expression of BAD in cultures of human syncytiotrophoblasts Am. J. Physiol. Cell Physiol. 299 2010 C968 C976
14. A. Desai, C. Victor-Vega, S. Gadangi, M.C. Montesinos, C.C. Chu, and B.N. Cronstein Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1 Mol. Pharmacol. 67 2005 1406 1413
15. A. Eljaszewicz, M. Wiese, A. Helmin-Basa, M. Jankowski, L. Gackowska, I. Kubiszewska, W. Kaszewski, J. Michalkiewicz, and W. Zegarski Collaborating with the enemy: function of macrophages in the development of neoplastic disease Mediators Inflamm. 2013 2013 1 11
16. A. Eroglu, O. Canbolat, S. Demirci, H. Kocaoglu, Y. Eryavuz, and H. Akgül Activities of adenosine deaminase and 5′-nucleotidase in cancerous and noncancerous human colorectal tissues Med. Oncol. 17 2000 319 324
17. I. Feoktistov, A.E. Goldstein, S. Ryzhov, D. Zeng, L. Belardinelli, T. Voyno-Yasenetskaya, and I. Biaggioni Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation Circ. Res. 90 2002 531 538
18. I. Feoktistov, S. Ryzhov, H. Zhong, A.E. Goldstein, A. Matafonov, D. Zeng, and I. Biaggioni Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype Hypertension 44 2004 649 654
19. P. Fishman, S. Bar-Yehuda, M. Synowitz, J.D. Powell, K.N. Klotz, S. Gessi, and P.A. Borea Adenosine receptors and cancer Handb. Exp. Pharmacol. 193 2009 399 441
20. G. Forte, R. Sorrentino, A. Montinaro, A. Luciano, I.M. Adcock, P. Maiolino, C. Arra, C. Cicala, A. Pinto, and S. Morello Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanoma J. Immunol. 189 2012 2226 2233
21. B.B. Fredholm Adenosine - a physiological or pathophysiological agent? J. Mol. Med. 92 2014 201 206
22. R.N. Gacche, and R.J. Meshram Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy Biochim. Biophys. Acta 1846 2014 161 179
23. C. Garlanda, C. Parravicini, M. Sironi, M. De Rossi, R. Wainstok de Calmanovici, F. Carozzi, F. Bussolino, F. Colotta, A. Mantovani, and A. Vecchi Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors Proc. Natl. Acad. Sci. U.S.A. 91 1994 7291 7295
24. S. Gessi, S. Merighi, K. Varani, E. Leung, S. Mac Lennan, and P.A. Borea The A3 adenosine receptor: an enigmatic player in cell biology Pharmacol. Ther. 117 2008 123 140
25. T. Hashikawa, M. Takedachi, M. Terakura, T. Saho, S. Yamada, L.F. Thompson, Y. Shimabukuro, and S. Murakami Involvement of CD73 (ecto-5′-nucleotidase) in adenosine generation by human gingival fibroblasts J. Dent. Res. 82 2003 888 892
26. S. Jalkanen, and M. Salmi VAP-1 and CD73 endothelial cell surface enzymes in leukocyte extravasation Arterioscler. Thromb. Vasc. Biol. 28 2008 18 26
27. K.E. Johnson, and T.A. Wilgus Vascular endothelial growth factor and angiogenesis in the regulation of cutaneous wound repair Adv Wound Care (New Rochelle) 3 2014 647 661
28. P. Koszalka, B. Özüyaman, Y. Huo, A. Zernecke, U. Flögel, N. Braun, A. Buchheiser, U.K.M. Decking, M.L. Smith, J. Sévigny, A. Gear, A. Weber, A. Molojavyi, Z. Ding, C. Weber, K. Ley, H. Zimmermann, A. Gödecke, and J. Schrader Targeted disruption of cd73/ecto-5′-nucleotidase alters thromboregulation and augments vascular inflammatory response Circ. Res. 95 2004 814 821
29. P. Koszałka, A. Pryszlak, M. Gołuńska, J. Kolasa, G. Stasiłojć, A.C. Składanowski, and J.J. Bigda Inhibition of CD73 stimulates the migration and invasion of B16F10 melanoma cells in vitro, but results in impaired angiogenesis and reduced melanoma growth in vivo Oncol. Rep. 31 2014 819 827
30. M.G. Lampugnani, F. Orsenigo, M.C. Gagliani, C. Tacchetti, and E. Dejana Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments J. Cell Biol. 174 2006 593 604
31. E. Lázár-Molnár, H. Hegyesi, S. Tóth, and A. Falus Autocrine and paracrine regulation by cytokines and growth factors in melanoma Cytokine 12 2000 547 554
32. S. Merighi, C. Simioni, S. Gessi, K. Varani, P. Mirandola, M.A. Tabrizi, P.G. Baraldi, and P.A. Borea A2B and A3 adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin Neoplasia 11 2009 1064 1073
33. F. Nassiri, M.D. Cusimano, B.W. Scheithauer, F. Rotondo, A. Fazio, G.M. Yousef, L.V. Syro, K. Kovacs, and R.V. Lloyd Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy Anticancer Res. 31 2011 2283 2290
34. A. Raz, W.L. McLella, I.R. Hart, C.D. Bucana, L.C. Hoyer, B.-A. Sela, P. Dragsten, and I.J. Fidler Cell surface properties of B16 melanoma variants with differing metastatic potential Cancer Res. 40 1980 1645 1651
35. R. Sadej, and A.C. Skladanowski Dual, enzymatic and non-enzymatic, function of ecto-5′-nucleotidase (eN, CD73) in migration and invasion of A375 melanoma cells Acta Biochim. Pol. 59 2012 647 652
36. F. Schroeder, and J.M. Gardiner Membrane lipids and enzymes of cultured high-and low-metastatic B16 melanoma variants Cancer Res. 44 1984 3262 3269
37. M. Shibuya Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases J. Biochem. 153 2013 13 19
38. J. Stagg, U. Divisekera, N. McLaughlin, J. Sharkey, S. Pommey, D. Denoyer, K.M. Dwyer, and M.J. Smyth Anti-CD73 antibody therapy inhibits breast tumor growth metastasis Proc. Natl. Acad. Sci. U.S.A. 107 2010 1547 1552
39. J. Stagg, U. Divisekera, H. Duret, T. Sparwasser, M.W. Teng, P.K. Darcy, and M.J. Smyth CD73-deficient mice have increased anti-tumor immunity and are resistant to experimental metastasis Cancer Res. 71 2011 2892 2900
40. A. Supernat, A. Markiewicz, M. Welnicka-Jaskiewicz, B. Seroczynska, J. Skokowski, A. Sejda, J. Szade, P. Czapiewski, W. Biernat, and A. Zaczek CD73 expression as a potential marker of good prognosis in breast carcinoma Appl. Immunohistochem. Mol. Morphol. 20 2012 103 107
41. V. Umansky, I. Shevchenko, A.V. Bazhin, and J. Utikal Extracellular adenosine metabolism in immune cells in melanoma Cancer Immunol. Immunother. 2014 (Epub ahead of print)
42. T. Veikkola, M. Karkkainen, L. Claesson-Welsh, and K. Alitalo Regulation of angiogenesis via vascular endothelial growth factor receptors Cancer Res. 60 2000 203 212
43. D.L. Vesely Family of peptides synthesized in the human body have anticancer effects Anticancer Res. 34 2014 1459 1466
44. E. Voronov, Y. Carmi, and R.N. Apte The role IL-1 in tumor-mediated angiogenesis Front. Physiol. 5 2014 114
45. L. Wang, J. Fan, L.F. Thompson, Y. Zhang, T. Shin, T.J. Curiel, and B. Zhang CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice J. Clin. Invest. 121 2011 2371 2382
46. L. Wang, S. Tang, Y. Wang, S. Xu, J. Yu, X. Zhi, Z. Ou, J. Yang, P. Zhou, and Z. Shao Ecto-5′-nucleotidase (CD73) promotes tumor angiogenesis Clin. Exp. Metastasis 30 2013 671 680
47. N. Weidner, J.P. Semple, W.R. Welch, and J. Folkman Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma N. Engl. J. Med. 324 1991 1 8
48. N. Weidner, P.R. Carroll, J. Flax, W. Blumenfeld, and J. Folkman Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma Am. J. Pathol. 143 1993 401 409
49. G.G. Yegutkin, F. Marttila-Ichihara, M. Karikoski, J. Niemelä, J.P. Laurila, K. Elima, S. Jalkanen, and M. Salmi Altered purinergic signaling in CD73-deficient mice inhibits tumor progression Eur. J. Immunol. 41 2011 1231 1241
50. J. Zhang, J. Cao, S. Ma, R. Dong, W. Meng, M. Ying, Q. Weng, Z. Chen, J. Ma, Q. Fang, Q. He, and B. Yang Tumor hypoxia enhances non-small cell lung cancer metastasis by selectively promoting macrophage M2 polarization through the activation of ERK signaling Oncotarget 5 2014 9664 9677
51. B. Zimmermann, M. Zebish, and N. Sträter Cellular function and molecular structure of ecto-nucleotidases Purinergic Signal. 8 2012 437 502